PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Kapo Saukkonen
Jaana Hagström
Harri Mustonen
Anne Juuti
Stig Nordling
Pauliina Kallio
Kari Alitalo
Hanna Seppänen
Caj Haglund
机构：
[1] University of Helsinki and Helsinki University Hospital,Department of Surgery
[2] University of Helsinki,Research Programs Unit, Translational Cancer Biology
[3] University of Helsinki and Helsinki University Hospital,Department of Pathology, Haartman Institute and HUSLAB
来源：
BMC Cancer | / 16卷
关键词：
Pancreatic ductal adenocarcinoma; Beta-catenin; PROX1; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma
    Wang, Huanyu
    Mao, Weilin
    Lou, Wenhui
    Jin, Dayong
    Wu, Wenchuan
    Wang, Dansong
    Kuang, Tiantao
    Rong, Yefei
    Xu, Xuefeng
    Zhang, Lei
    JOURNAL OF CANCER, 2022, 13 (05): : 1501 - 1511
  • [22] Prognostic and predictive markers in pancreatic adenocarcinoma
    Le, Nha
    Sund, Malin
    Vinci, Alessio
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (03) : 223 - 230
  • [23] Podoplanin and PROX1 Expression in Hypercaloric Diet-induced Pancreatic Injuries
    Taran, Delia
    Tarlui, Valeria Nicoleta
    Ceausu, Raluca Amalia
    Cimpean, Anca Maria
    Raica, Marius
    Sarb, Simona
    IN VIVO, 2019, 33 (04): : 1157 - 1163
  • [24] Establishment of Three Gene Prognostic Markers in Pancreatic Ductal Adenocarcinoma Using Machine Learning Approach
    Pragya, Pragya
    Govarthan, Praveen Kumar
    Nayak, Malay
    Mukherjee, Sudip
    Ronickom, Jac Fredo Agastinose
    JOURNAL OF MEDICAL AND BIOLOGICAL ENGINEERING, 2024, 44 (03) : 357 - 365
  • [25] Implications of PPPDE1 expression in the distribution of plakoglobin and β-catenin in pancreatic ductal adenocarcinoma
    Kang, Yu-Huan
    Shen, Cong-Cong
    Yao, Yu-Qin
    Yu, Lin
    Cui, Xin-Yi
    He, Yi
    Yang, Jin-Liang
    Gou, Lan-Tu
    ONCOLOGY LETTERS, 2014, 8 (03) : 1229 - 1233
  • [26] microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma
    Frampton, Adam E.
    Krell, Jonathan
    Jacob, Jimmy
    Stebbing, Justin
    Jiao, Long R.
    Castellano, Leandro
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (12) : 1837 - 1842
  • [27] Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
    Shen, Quan
    Yu, Miao
    Jia, Jiang-Kun
    Li, Wen-Xi
    Tian, Yu-Wei
    Xue, Huan-Zhou
    MEDICAL SCIENCE MONITOR, 2018, 24 : 2368 - 2376
  • [28] Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma
    Li, Qing
    Wang, Hao
    Zogopoulos, George
    Shao, Qin
    Dong, Kun
    Lv, Fudong
    Nwilati, Karam
    Gui, Xian-Yong
    Cuggia, Adeline
    Liu, Jun-Li
    Gao, Zu-Hua
    ONCOTARGET, 2016, 7 (47) : 77838 - 77853
  • [29] Clinical implications of biological markers in pancreatic ductal adenocarcinoma
    Giovinazzo, Francesco
    Turri, Giulia
    Zanini, Sara
    Butturini, Giovanni
    Scarpa, Aldo
    Bassi, Claudio
    SURGICAL ONCOLOGY-OXFORD, 2012, 21 (04): : E171 - E182
  • [30] Cancer stem cell markers in pancreatic ductal adenocarcinoma
    Aksoy, F.
    Kaya, E.
    Egeli, U.
    Dundar, H. Z.
    Tasar, P.
    Aksoy, S. A.
    Ozen, Y.
    Tunca, B.
    Cecener, G.
    Yerci, O.
    ANNALS OF ONCOLOGY, 2018, 29
12345